Rilunermin alfa
Rilunermin alfa (SCB-313) is a recombinant fusion protein composed of the human C-propeptide of alpha1 (I) collagen (Trimer-Tag) to the C-terminus of the mature human tumor necrosis factor (TNF) -related apoptosis-inducing ligand (TRAIL; Apo2L) . Rilunermin alfa has potential pro-apoptotic and antineoplastic activities[1].
Product Specifications
CAS Number
2254278-53-8
Product Name Alternative
SCB-313
UNSPSC
12352203
Target
Apoptosis; Drug Derivative
Type
Inhibitory Antibodies
Related Pathways
Apoptosis; Others
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/rilunermin-alfa.html
Solubility
10 mM in DMSO
Smiles
[Rilunerminalfa]
References & Citations
[1]Peng Liang, et al. Method and Compositions for Producing Disulfide-Linked Trimeric TNF Family of Cytokines and Their Use. Patent. US20180346549 A1.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 1
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
B0807-12B-ML550 100 µL
Bcl 10 (B Cell Leukemia 10, CIPER, mE10, CARMEN, CLAP) (MaxLight 550) discontinued
Sign In for Pricing
View Details